ESC 365 - Pre-treatment with P2Y12 inhibitors in acute myocardial infarction with cardiogenic shock

ESC Professional Premium Access

Pre-treatment with P2Y12 inhibitors in acute myocardial infarction with cardiogenic shock

Session: New perspectives in cardiology (2) - Antithrombotic pharmacotherapy

Topic: Antiplatelet Drugs

Speaker: Associate Professor M. Zeitouni (Paris, FR)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Associate Professor Michel Zeitouni

Pitie Salpetriere APHP University Hospital, Paris (France)

0 follower

9 more presentations in this session

Discussant - Antithrombotic pharmacotherapy

Safety and efficacy of factor XI/XIa inhibitors compared to factor Xa inhibitors for stroke prophylaxis in atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials

Speaker: Mr G. Arrighini (Bologna, IT)

Sex differences in dual antiplatelet therapy de-Escalation strategies in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis

Speaker: Doctor G. Occhipinti (Barcelona, ES)

Platelet reactivity of clopidogrel and aspirin with or without omeprazole in diabetes mellitus and coronary artery disease in thailand: a randomised double-blind placebo-controlled cross-over trial

Speaker: Doctor M. Thungthienthong (Bangkok, TH)

Sex-related variations in platelet reactivity in presence or absence of antiplatelet therapy

Speaker: Doctor M. Galli (Rome, IT)

Access the full session

New perspectives in cardiology (2) - Antithrombotic pharmacotherapy

Speakers: Associate Professor M. Zeitouni, Mr G. Arrighini, Doctor G. Occhipinti, Doctor M. Thungthienthong, Doctor M. Galli

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources